You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 12, 2025

Bulk Pharmaceutical API Sources for rubidium chloride rb-82


✉ Email this page to a colleague

« Back to Dashboard


Bulk Pharmaceutical API Sources for rubidium chloride rb-82

Vendor Vendor Homepage Vendor Sku API Url
NovoSeek ⤷  Get Started Free 71357 ⤷  Get Started Free
ABI Chem ⤷  Get Started Free AC1L2G0E ⤷  Get Started Free
BenchChem ⤷  Get Started Free B1210196 ⤷  Get Started Free
THE BioTek ⤷  Get Started Free bt-1548106 ⤷  Get Started Free
J&H Chemical Co.,ltd ⤷  Get Started Free JH118551 ⤷  Get Started Free
RR Scientific ⤷  Get Started Free R583003 ⤷  Get Started Free
>Vendor >Vendor Homepage >Vendor Sku >API Url

Bulk Active Pharmaceutical Ingredient (API) Sources for Rubidium Chloride (Rb-82)

Last updated: August 2, 2025

Introduction

Rubidium-82 (Rb-82) is a radioactive isotope primarily utilized in positron emission tomography (PET) imaging for cardiac perfusion assessments. As a radiopharmaceutical, Rb-82 is synthesized from a generator system rather than produced directly in a conventional chemical manufacturing process. Its active pharmaceutical ingredient (API), rubidium chloride (RbCl), is indispensable for radiotracer preparation. Consequently, sourcing bulk RbCl for medical purposes involves a specialized supply chain emphasizing radiochemical purity, regulatory compliance, and timely delivery.

This analysis explores the key sources, manufacturing considerations, and regulatory landscape governing bulk RbCl supply for medical applications.


Understanding Rb-82 and RbCl in Medical Context

Rubidium chloride (RbCl) serves as the precursor material for generating Rb-82 via generator systems, most notably the Rubidium Generator (e.g., CardioGen-82). The generator contains strontium-82 (Sr-82), which decays to Rb-82, facilitating in-situ elution of the isotope.

While Rb-82 itself, as a radiotracer, does not typically exist in bulk chemical form outside the generator, the preparation and calibration of the imaging agent depend on high-purity bulk RbCl. The API must meet stringent standards to ensure safety, efficacy, and regulatory compliance across diverse markets.


Manufacturers and Suppliers of Bulk RbCl

1. Specialized Chemical & Radiochemical Suppliers

Most suppliers of bulk RbCl are specialized companies providing high-purity chemical-grade or pharmaceutical-grade RbCl tailored for radiopharmaceutical manufacturing. Their offerings encompass different grades, including:

  • Analytical Grade: Utilized in research and development, with specifications emphasizing purity for analytical purposes.
  • Pharmaceutical Grade: Compliant with Good Manufacturing Practice (GMP) standards, essential for clinical and commercial radiopharmaceutical preparation.

Leading Suppliers:

  • American Radiolabeled Chemicals (ARC): A prominent supplier providing GMP-grade RbCl suitable for radiotracer manufacturing, emphasizing purity, stability, and regulatory compliance. ARC supplies both bulk RbCl and ready-to-use kits for Rb-82 generator calibration.

  • PerkinElmer (formerly PerkinElmer Radiochemicals): Offers various radiopharmaceutical raw materials, including RbCl, with a focus on high purity and consistent quality. Their products often conform to pharmacopeial standards and meet the needs of hospitals and radiopharmacies.

  • International Isotopes Inc.: A US-based company specializing in medical isotopes and precursor chemicals such as RbCl, including licensed and GMP-compliant supplies adhering to regulatory standards.

  • Isorasb (France): Provides chemically pure RbCl used for generator manufacturing in Europe, with strict compliance to regional pharmacopeias and GMP standards.


2. Generator Manufacturers

Some companies manufacture not only the Rb-82 generator systems but also supply the precursor RbCl necessary for elution:

  • CardioGen-82 (Bracco Diagnostics): While primarily offering the Rb-82 generator, Bracco offers guidance and supplied materials compatible with their systems.

  • Eckert & Ziegler: A European manufacturer offering Rb-82 generators and some related materials, often including precursor RbCl for the initial setup.

  • Nordion (formerly Nordion): Historically involved in isotope production and could be involved in supply chains related to medical isotopes, including RbCl for generator calibration.


Regulatory and Quality Considerations

Given its application in human imaging, Rb-Cl used as API must meet:

  • Pharmacopoeial standards (USP, EP, JP): Impose limits on impurities, heavy metals, endotoxins, and radionuclidic purity.

  • GMP compliance: Ensures consistent quality suitable for clinical use, including validation, stability, and sterility.

  • Radiochemical purity: Must be tightly controlled, as Rb-82 must be produced from highly purified RbCl to avoid patient exposure to impurities.

  • Licensing: Suppliers must possess appropriate licenses granted by agencies such as the FDA (US), EMA (Europe), or respective local health authorities.


Challenges in Sourcing Bulk RbCl

  • Regulatory Complexity: Navigating regional compliance requirements, especially for radiopharmaceutical-grade materials.

  • Limited Supply Chain: Due to the niche application and high purity standards, few suppliers operate at large scale, creating potential supply constraints.

  • Cost Factors: High purity, GMP compliance, and regulatory licensing contribute to elevated costs, affecting procurement budgets.

  • Logistics: Radioactive and chemical handling necessitates secure transportation, storage, and handling protocols.


Emerging Trends and Future Outlook

The expansion of PET imaging, particularly in cardiology, increases demand for Rb-82 and, consequently, the need for high-quality RbCl precursor supplies. Innovations include:

  • Development of more robust generator technologies that optimize Rb-82 elution efficiency, reducing the quantity needed for each dose—thereby decreasing demand for bulk RbCl.

  • Increasing regulatory harmonization across regions, easing import/export barriers.

  • Potential local manufacturing initiatives to reduce supply chain fragility.

As competition intensifies and technological advancements occur, expect more suppliers entering the market, broadening availability.


Conclusion

The sourcing of bulk RbCl API for radiopharmaceutical use hinges on specialized suppliers capable of providing high-purity, GMP-grade materials that meet rigorous regulatory standards. Leading companies like ARC, PerkinElmer, and Isorasb are prominent providers, supporting the expanding demand driven by PET imaging modalities. However, supply chain constraints and regulatory complexities necessitate strategic procurement planning for healthcare providers and radiopharmacies.


Key Takeaways

  • Limited supplier base: Only select companies supply GMP-grade RbCl suitable for medical applications.

  • Regulatory compliance is critical: All sources must meet pharmacopeial standards and national licensing requirements.

  • Cost and logistics: High-quality RbCl is expensive and requires careful handling, storage, and transportation.

  • Market growth fuels demand: Increasing adoption of Rb-82 PET imaging drives the need for reliable API sources.

  • Future innovations: Emerging generator efficiencies and regional manufacturing could alleviate supply constraints.


FAQs

Q1: Can I procure bulk RbCl without regulatory oversight?
A: No. Medical-grade RbCl used in radiopharmaceutical applications must be sourced from licensed, GMP-compliant suppliers to ensure safety and efficacy standards are met.

Q2: What are the primary quality standards for pharmaceutical-grade RbCl?
A: The key standards include purity (chemical and radiochemical), endotoxin levels, heavy metals content, and radionuclidic purity, all aligned with USP, EP, or JP pharmacopeias.

Q3: Is there a difference between analytical grade and pharmaceutical grade RbCl?
A: Yes. Analytical grade is suitable for research, while pharmaceutical grade meets stricter regulatory standards required for human administration.

Q4: How does supply chain reliability impact radiopharmaceutical production?
A: Limited suppliers and stringent regulations can lead to shortages or delays, impacting clinical workflows and patient care.

Q5: Are regional manufacturers expanding to meet the rising demand for RbCl?
A: Yes. Several regional players are investing in GMP manufacturing capabilities to reduce dependency on imports and improve supply resilience.


Sources:

  1. [1] American Radiolabeled Chemicals (ARC). Product specifications for RbCl.
  2. [2] PerkinElmer. Radiopharmaceutical raw materials catalog.
  3. [3] European Pharmacopoeia. Standards for radiopharmaceutical ingredients.
  4. [4] U.S. Food and Drug Administration. Regulations for radiopharmaceutical manufacturing.
  5. [5] Eckert & Ziegler. Rb-82 generator and precursor details.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.